Dietary enrichment of eggs with omega-3 fatty acids: a review
When used as part of CagriSema, the dosing schedule looked like this in trials: Weeks 04: 0.25 mg cagrilintide + 0.25 mg semaglutide Weeks 48: 0.5 mg + 0.5 mg Weeks 812: 1 mg + 1 mg Weeks 1216: 1.7 mg + 1.7 mg Week 16 onward: 2.4 mg + 2.4 mg (full maintenance dose) Until the medication is approved and prescribing information is finalized, any dosing decisions would only happen through participation in a clinical trial or, eventually, under the guidance of a healthcare provider
As a result, research teams often emphasize controlled observation, standardized reporting practices, and structured data management procedures
(5) Kopchick JJ, Berryman DE, Puri V, Lee KY, Jorgensen JOL
A 2025 retrospective analysis published in Ophthalmology Retina evaluated the incidence of DME among patients with type 2 diabetes who took various classes of medications